Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Murali Prahalad, Stephen Chanock

Premium

Epic Sciences has appointed Murali Prahalad as President and CEO. Prahalad joins Epic from Life Technologies where he was vice president of corporate strategy and helped shape investment priorities in research tools, clinical diagnostics, and applied markets.


The National Cancer Institute has appointed Stephen Chanock to be director of NCI’s Division of Cancer Epidemiology and Genetics and a scientific director of the institute.

Chanock takes over DCEG from founding Director Joseph Fraumeni, who stepped down from the post a year ago.

Chanock formerly was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in NCI’s Center for Cancer Research, he was co-chair of NCI’s Genetics, Genomics, and Proteomics Faculty, and he was chief of the Cancer Genomics Research Laboratory and the Laboratory of Translational Genomics. He also was acting director of the NCI Center for Cancer Genomics from 2012 to 2013.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.